ICIS Events and Educational Opportunities
From our renowned Annual Conferences to engaging workshops, free webinars, and insightful reflections on past events, we offer a wide range of opportunities for anyone looking to expand their knowledge of oncological imaging.

The 25th International Cancer Imaging Society Meeting and Annual Teaching Course – Abstract Presenter Booking
Price: £95.00 – £470.00
The theme for this year’s ICIS 2026 is: The Fundamentals of Cancer Imaging with Automated Assistance. Join us to explore how cutting-edge imaging is transforming cancer care, equipping you to see beyond the scan, make smarter clinical decisions, and deliver better patient outcomes. This dynamic teaching course brings together innovation, expertise, and real-world insight to […]
Days to Meeting
Letter from our President
Dear Colleagues and Friends,
On behalf of the International Cancer Imaging Society (ICIS), it is my great pleasure to invite you to join us in Belfast, Northern Ireland, for ICIS 2026, our 25th Annual Teaching Course, to be hosted in collaboration with the Faculty of Radiologists & Radiation Oncologists of the Royal College of Surgeons in Ireland (RCSI). The focus of the meeting will be
‘Fundamentals of Imaging Cancer with Automated Assistance’.
The main vision for the conference is to reaffirm the foundational principles in cancer imaging while highlighting the growing contribution of automated assistance within clinical practice. By working together with leading industrial partners, participants will gain insight into both established and emerging imaging automation techniques that are shaping the future of oncological imaging. The comprehensive programme will include keynote lectures, plenary lectures, breakout sessions, hands-on workshops and scientific presentations.
* Stay at the forefront of oncological imaging
* Network with global experts
* Gain insights into the latest advancements in cancer diagnostics and AI-driven imaging techniques
As a city renowned for its commitment to sustainability, Belfast offers an eco-conscious setting for our annual event; attendees can explore cutting-edge research while experiencing a city that prioritises environmental responsibility, aligning with the healthcare sector’s growing focus on sustainability.
We hope you will join us in Belfast for ICIS 2026!
Warmest regards,
Anju Sahdev, President, ICIS 2026
Professor of Radiology, St Bartholomew’s Hospital, London.

Learning Objectives
- To understand the role of precision imaging and advanced image guided interventions in oncology.
- To appreciate the evolving role of cancer imaging in modern clinical-radiological integrated practice, in particular the role of objective, imaging based anatomical and functional biomarkers to guide and monitor cancer treatment.
- To recognise the significance of large objective imaging data sets for artificial intelligence based oncologic algorithms.
- To improve clinical reporting skills through interactive case-based workshops.
- To review recent research findings and innovations in the field of diagnostic and interventional radiology.
| Time | Session |
|---|---|
| 08:00 – 08:45 | Registration |
| 08:45 – 09:00 |
President's Welcome
A. Sahdev
|
| 09:00 – 10:30 |
Focus on AI in Cancer Imaging
A. Sohaib
|
| 09:00 – 09:20 |
Introduction to AA and AI in medical imaging. Where are we currently?
S. Harden
|
| 09:20 – 09:40 |
Overcoming MRI accessibility barriers in cancer imaging with cutting-edge solutions
H. Chandarana
|
| 09:40 – 10:00 |
Platforms for development & marketplace for AA & AI selection
K. Chiu
|
| 10:00 – 10:20 |
Continuous evaluation of AI systems in cancer imaging
F. Prior
|
| 10:20 – 10:30 | Questions & discussion |
| 10:30 – 11:00 | Break |
| 11:00 – 12:30 |
Breast and Gynaecological
S. Vinnicombe
|
| 11:00 – 11:20 |
Molecular imaging of breast cancer: clinical impact and correlation with other imaging modalities
M. Queiroz
|
| 11:20 – 11:40 |
Computer-assisted diagnosis for mammography & ultrasound
M. Kataoka
|
| 11:40 – 12:00 |
The dense breast problem: where next?
S. Vinnicombe
|
| 12:00 – 12:20 |
AI-Assisted opportunistic detection of ovarian cancer on routine body CT and MRI
G. Lin
|
| 12:20 – 12:30 | Questions & discussion |
| 11:00 – 12:30 |
Obstetrics and Gynaecological
R. Forstner
|
| 11:00 – 11:25 |
Pregnancy: novel, intrauterine treatment options for fetal tumours
T. Huisman
|
| 11:25 – 11:50 |
Fertility preserving treatments for gynaecological cancers
R. Forstner
|
| 11:50 – 12:00 | Questions & discussion |
| 12:00 – 12:30 |
Scientific Session 1
R. Gore
|
| 11:00 – 12:30 |
Hands-on Workshop 1:
Prostate MRI and PSMA PET
J. Fütterer & M. Naik
|
| 12:30 – 13:45 | Lunch & 30-minute Sponsored Symposium |
| 13:45 – 14:15 |
Keynote Lecture 1:
From models to agents: The next AI revolution in oncology
N. Papanikolaou
|
| 14:15 – 15:45 |
Staging and Treatment Planning
C. Collins
|
| 14:15 – 14:40 |
Prostate cancer: disease staging & treatment planning with AI
P. Asbach
|
| 14:40 – 15:05 |
Treatment planning for pancreatic ductal adenocarcinoma
J. Heiken
|
| 15:05 – 15:30 |
Image-guided oncologic treatments and guidelines
J. Fütterer
|
| 15:30 – 15:45 | Questions & discussion |
| 14:15 – 15:45 |
Extended Uses of AI
H. Chandarana
|
| 14:15 – 14:40 |
Disease-specific structured reporting & automated assistance
A. Shinagare
|
| 14:40 – 15:05 |
Lung cancer screening with focus on AI
S. Digumarthy
|
| 15:05 – 15:30 |
Liver cancer response evaluation
B. Taouli
|
| 15:30 – 15:45 | Questions & discussion |
| 15:45 – 16:15 | Break |
| 16:15 – 17:45 |
Paediatrics
T. Huisman
|
| 16:15 – 16:35 |
Bone marrow malignancies in children and adolescents
J. Carrino
|
| 16:35 – 16:55 |
Paediatrics: AI in paediatric oncology
M. Lequin
|
| 16:55 – 17:15 |
LEAT: low-grade epilepsy associated tumours
G. Morana
|
| 17:15 – 17:35 |
Paediatric germ cell tumours: imaging strategies for diagnosis & management
S. Voss
|
| 17:35 – 17:45 | Questions & discussion |
| 16:15 – 17:30 |
Local Site Level Experience with AA & AI
F. Fennessy
|
| 16:15 – 16:35 |
1 year experience after implementation of a structured reporting software with integrated AI for mpMRI in the daily routine
T. Persigehl
|
| 16:35 – 16:55 |
The Royal Marsden experience with deep resolve in MRI
G. C. Edwards
|
| 16:55 – 17:15 |
AI agentic system that supports MDT meetings & tumour boards
N. Papanikolaou
|
| 17:15 – 17:45 |
Scientific Session 2
C. Collins
|
| 16:15 – 17:45 |
Hands-on Workshop 2
WB-MRI Myeloma
C. Messiou & M. Koh
|
| 17:45 | Welcome Reception |
| Time | Session |
|---|---|
| 08:00 – 09:00 | Registration |
| 08:30 – 09:00 | Breakfast Symposium (Sponsored) |
| 09:00 – 10:30 |
Joint ICIS and FRRO Session
A. Sahdev & E. Davis
|
| 09:00 – 09:20 |
Imaging extranodal capsular extension in head and neck cancers
K. Bhatia
|
| 09:20 – 09:40 |
Mimics and rare head and neck tumours
T.T. Zhang
|
| 09:40 – 10:00 |
Decoding anterior tongue carcinoma beyond TNM: Indian multi-centric, real-world data on molecular profiling and immunity in relation to clinical outcome–A divide, dive deep, and conquer approach
S. Swamy
|
| 10:00 – 10:20 |
Unrestricted and unmonitored: Why physicians must reclaim
governance of AI in imaging and oncology
D. Comeau
|
| 10:20 – 10:30 | Questions & discussion |
| 10:30 – 11:00 | Break |
| 11:00 – 11:30 |
Keynote Lecture 2:
Cancer Imaging: The foundation supporting the pillars of cancer treatment including AI
A. Van den Abbeele
|
| 11:30 – 13:00 |
Hepatobiliary
J. Heiken
|
| 11:30 – 11:50 |
Unusual presentation of common pancreatic tumours
M. D'Onofrio
|
| 11:50 – 12:10 |
Diagnostic approach & pitfalls of enhancing lesions in non-cirrhotic liver
K. Elsayes
|
| 12:10 – 12:30 |
Cholangiocarcinoma: classification, staging & resectability assessment including liver transplantation
K. Jhaveri
|
| 12:30 – 13:00 |
Scientific Session 3
A. Van Den Abbeele
|
| 11:30 – 13:00 |
Disease Characterisation, Scoring & AA
A. Shinagare
|
| 11:30 – 11:50 |
ONCO-RADS
G. Petralia
|
| 11:50 – 12:10 |
AI-assistance for quantifying metastatic bone disease
M. Koh
|
| 12:10 – 12:30 |
O-RADS
A. Shinagare
|
| 12:30 – 13:00 |
Scientific Session 4
A. Sohaib
|
| 11:30 – 13:00 |
Hands-on Workshop 3:
RECIST 1.1, iRECIST, CHESON & Lugano
M. Queiroz & O. Lucidarme
|
| 13:00 – 14:15 | Lunch & 30-minute Sponsored Symposium |
| 14:15 – 15:45 |
Treatment Response Evaluation and AA
S. Diederich
|
| 14:15 – 14:30 |
Gold Medal presentation
R. Reznek & A. Sahdev
|
| 14:30 – 14:50 |
Imaging of lymphoma & updates to the Lugano classification
M. Mayerhoefer
|
| 14:50 – 15:10 |
RECIST 1.1, iRECIST & CHESON
B. Gebauer
|
| 15:10 – 15:30 |
New methods of assessing tumour response to immunotherapy and CAR T-cell therapy: when to resist RECIST
R. Gore
|
| 15:30 – 15:45 | Questions & discussion |
| 15:45 – 16:15 | Break |
| 16:15 – 17:45 |
Theranostics and Molecular Imaging
W. Oyen
|
| 16:15 – 16:40 |
Emerging tracers for molecular imaging
W. Oyen
|
| 16:40 – 17:05 |
Theranostics: state of the art and new concepts
M. Hofman
|
| 17:05 – 17:30 |
Neuroendocrine tumours: PET/CT DOTATATE for staging and treatment planning
T. Barwick
|
| 17:30 – 17:45 | Questions & discussion |
| 16:15 – 17:45 |
Unravelling Immunohistochemistry for Radiologists
K. Elsayes
|
| 16:15 – 16:35 |
Lung cancer in the era of molecular testing
S. Digumarthy
|
| 16:35 – 16:55 |
Endometrial cancer & IHC
F. Fennessy
|
| 16:55 – 17:15 |
Role of IHC in screening, diagnosis, immunotherapy selection, treatment response assessment of abdominal tumours
R. Gore
|
| 17:15 – 17:35 |
IHC in HCC
W. Schima
|
| 17:35 – 17:45 | Questions & discussion |
| 16:15 – 17:45 |
Hands-on Workshop 4:
Rectal Cancer MRI – Baseline & Post-Treatment Response Assessment
K. Jhaveri
|
| 19:30 |
Course Dinner at Belfast City Hall
|
| Time | Session |
|---|---|
| 09:00 – 10:30 |
Unusual Tumours
W. Schima
|
| 09:00 – 09:20 |
Uncommon primary and secondary pancreatic neoplastic lesions
M. A. Bali
|
| 09:20 – 09:40 |
Unusual mesenteric and colorectal lesions
W. Schima
|
| 09:40 – 10:00 |
Rare pelvic masses
R. Forstner
|
| 10:00 – 10:20 |
Rare retroperitoneal masses
C. Messiou
|
| 10:20 – 10:30 | Questions & discussion |
| 10:30 – 11:00 | Break and presentation of prizes for scientific presentations & posters |
| 11:00 – 11:30 |
Keynote lecture 3: Ovarian cancer screening update: where are we currently?
R. Manchanda
|
| 11:30 – 13:00 |
Practice Change & Clinical Trials Update
C. Messiou
|
| 11:30 – 11:50 |
Role of AI and breast trials AI update
S. Vinnicombe
|
| 11:50 – 12:10 |
Important new trials in gynaecological cancers
A. Sohaib
|
| 12:10 – 12:30 |
Role of advanced imaging in driving practice change in renal
cancer and kidney diseases
H. Chandarana
|
| 12:30 – 12:50 |
Oligometastatic disease: a window of opportunity and the evidence for intervention
G. Petralia
|
| 12:50 – 13:00 | Questions & discussion |
| 11:30 – 13:00 |
Mimics of Malignancy
F. Fennessy
|
| 11:30 – 11:50 |
Mimics of gynaecological cancer
F. Fennessy
|
| 11:50 – 12:10 |
Mimics of lung cancer
S. Diederich
|
| 12:10 – 12:30 |
Mimics of bone metastases
M. Naik
|
| 12:30 – 12:50 |
Mimics of hepatobiliary cancers
M. D'Onofrio
|
| 12:50 – 13:00 | Questions & discussion |
| 11:30 – 13:00 |
Hands-on Workshop 5: Imaging and pathological correlation with cases in pancreatic cancer
C. Matos
|
| 13:00 – 14:00 | Lunch |
| 14:00 – 15:30 |
Treatment Complications
A. Sohaib
|
| 14:00 – 14:20 |
Abdominal complications of novel cancer therapies
R. Gore
|
| 14:20 – 14:40 |
Complications of cancer treatment in the lung
S. Diederich
|
| 14:40 – 15:00 |
Immunotherapy associated neurotoxicity
G. Morana
|
| 15:00 – 15:20 |
Efforts to improve MRI quality in cancer imaging
K. Gormly
|
| 15:20 – 15:30 | Questions & discussion |
| 15:30 | Close & Thanks |

The Europa Hotel Belfast
The Europa Hotel Belfast, Northern Ireland
The Europa Hotel Belfast, Northern Ireland
ICIS 2026 Essentials - About BelfastAccreditation
Royal College of Radiologists accreditation has been applied for.
EACCME (European Accreditation Council for Continuing Medical Education) accreditation has been applied for.
Meet The Speakers
Prof Anju Sahdev
President
Dr Mitesh Naik
Prof Jurgen Futterer
Prof Christina Messiou
Prof Dow-Mu Koh
Prof
Prof. Koh obtained his primary medical degree in Singapore (1989). Following further training in internal medicine and diagnostic radiology, he was awarded the fellowship of the Royal College of Radiologist (UK) in 1996. He was appointed to the position of Consultant Radiologist in Functional Imaging at the Royal Marsden Hospital in January 2008 and was conferred the title of Professor in Functional Cancer Imaging at the Institute of Cancer Research in 2015. Prof. Koh’s current clinical and research interest is in the development and application of functional imaging techniques for tumour assessment. He has a particular interest in developing and evaluating diffusion-weighted MR imaging in the body (DWI), to enhance and improve the ability to detect and characterise tumours, as well as to monitor the effects of conventional and novel therapeutics. Prof. Koh is the Imaging Theme Lead for the National Institute of Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research. In 2015, he was appointed a member of the National Cancer Research Institute (NCRI) Imaging Biomarker Advisory Board in the UK. In addition to his research, Prof. Koh lectures regularly at numerous conferences and courses, including the European Congress of Radiology (ECR), European School of Radiology (ESOR), European Society of Gastrointestinal and Abdominal Radiology (ESGAR), International Society of Magnetic Resonance in Medicine meetings (ISMRM) and the Radiological Society of North America (RSNA) meetings. He was named outstanding teacher by the ISMRM in 2008, 2009 and 2012. Prof. Koh was elected a Fellow of the International Cancer Imaging Society (ICIS) (2007) and appointed Honorary Treasurer of the Society in 2011. He is series organiser for the ICIS interactive courses, a hands-on teaching course; and also the course organiser of the Body DWI course on behalf of the ESMRMB School of MRI. Prof. Koh is currently an associate editor for Radiology, and also reviews regularly for other radiological and medical journals. He was awarded the Barclay Medal in 2013 for his contributions to the British Journal of Radiology. Prof. Koh has had numerous publications in peer reviewed journals and textbooks. In 2009 he co-edited a book, ‘Diffusion-weighted MRI: Applications in the Body’, published by Springer.
Dr Marcelo Queiroz
Prof Olivier Lucidarme
Deputy Editor
Dr Kartik Jhaveri
Prof Celso Matos
Vice President
Celso Matos studied medicine at the Medical School of the University of Brussels, Belgium and obtained his Medical Degree Magna Cum Laude in 1980. After a fellowship in Internal Medicine and Rheumatology at the University of Brussels, he started his fellowship in Radiology at the department of Radiology at Erasme University Hospital in Brussels, Belgium in 1983. As a board certified radiologist he joined the faculty in this department and led the MR imaging division since 1990. He became Professor of Clinical Radiology in 2001 at Erasme University Hospital. In late 2015 Celso Matos moved to Lisbon to start his current position as Head of the Imaging department at the Champalimaud Centre for the Unknown and co Director of Champalimaud Research for clinical investigation. Celso Matos has been President of the ESGAR (European Society for Abdominal and Gastrointestinal Radiology). As a radiologist he contributes to the imaging programme of several annual meetings and regularly co-organises radiological-clinical educational events. Celso Matos’ main areas of clinical and research interest are abdominal and oncologic imaging. His main focus is multidisciplinary research in pancreatic cancer and related disorders. Celso Matos has been part of the Abdominal Section of the European Radiology Editorial Board since 2014 and has been appointed Associate Editor of Radiology in November 2016.He received the European School of Radiology Best teacher Award in 2014.
Dr Hersh Chandarana
Dr. Chandarana is a tenured Professor of Radiology, Associate Chair for Clinical and Translational Research, and physician-scientist in the Department of Radiology at the New York University Grossman School of Medicine. Dr. Chandarana has interest and experience in the development and application of advanced imaging techniques to study pathophysiology of abdominopelvic diseases, with special interest in oncologic imaging. His extensive and productive collaborative efforts with clinicians and basic scientists as well as industry scientists allows him to collaboratively address important clinical problems.
Dr Masako Kataoka
Dr Sarah Vinnicombe
Dr Gigin Lin
President Elect
Dr. Gigin Lin is a physician-scientist specializing in medical imaging and cancer research. He holds an M.D. from Chang Gung University and a Ph.D. in Biochemistry from the Institute of Cancer Research at the University of London. He is currently a Professor of Radiology at Chang Gung Memorial Hospital in Taiwan. His translational research bridges clinical radiology and computational sciences, focusing on AI-enabled imaging for cancer detection, treatment monitoring, and biomarker discovery. A Fellow of the International Cancer Imaging Society, he has received national awards and international recognition, including invited lectures at ISMRM and RSNA. Dr. Lin’s research integrates advanced imaging, molecular biomarkers, and artificial intelligence to improve cancer diagnosis and treatment. His work spans molecular imaging with CT, PET, and MRI to identify imaging surrogates of tumor biology; clinical metabolomics to discover novel biomarkers and therapeutic targets; and AI-driven tools such as automated tumor segmentation, radiomics analysis, and outcome prediction across multiple cancers. He has also advanced Hyperpolarised C13 MRI, developing metabolic biomarkers to enhance treatment response. Through these multidisciplinary efforts, Dr. Lin aims to translate cutting-edge imaging and computational technologies into precision oncology applications that directly impact patient care.
Thierry Huisman
Immediate Past President
Thierry A.G.M. Huisman is the current Radiologist-in-Chief and TCH Chair of the Department of Radiology at Texas Children’s Hospital in Houston, USA. He also holds the Edward B. Singleton Chair of Radiology. He is a tenured Professor of Radiology, Pediatrics, Neurosurgery, Neurology, Obstetrics and Gynecology at Baylor College of Medicine and holds adjunct Professor Appointments at Johns Hopkins School of Medicine in Neurosurgery and Pediatrics. Before he joined TCH he served 11 years at Johns Hopkins Medicine in Baltimore. He was the Chairman of the Department of Imaging and Imaging Science at the Johns Hopkins Bayview Medical Center. In addition, he was the Director of the Division of Pediatric Radiology, Director and founder of the Division of Pediatric Neuroradiology at the Johns Hopkins Hospital in Baltimore and Co-Director of the Neurointensive Care Nursery (NICN), the Johns Hopkins Fetal Program and the Center for Translational and Molecular Imaging (CTMI). Prior to his tenure at Johns Hopkins he was the Chairman and Radiologist-in-Chief of the Department of Diagnostic Imaging at the University Children’s Hospital Zurich. He graduated cum laude from Medical School at the Erasmus University in Rotterdam, the Netherlands, before completing residencies in Radiology and Pediatrics and fellowships in Pediatric Radiology and Neuroradiology at the University Hospital Zurich, Switzerland. Dr. Huisman enjoyed a 2.5-year research sabbatical at the Massachusetts General Hospital NMR center, Harvard Medical School in Boston. His primary field of expertise and research focuses on advanced, quantitative, precision imaging in the field of Neuroradiology. He has given more than 480 invited lectures, published 430 articles and 31 reviews, 67 book chapters, 6 text books, serves on multiple scientific committees of the various radiological societies and has organized multiple national and international meetings in Europe and the USA. He has been one of the founding members of the Swiss Symposium in Pediatric Neuroradiology and the Neurointensive Care Nursery at Johns Hopkins. Dr. Huisman served as a faculty member of the AIRP course in Washington, DC (2013-2019), and is a course advisor for the IDKD course in Davos, Switzerland since 2012. Furthermore, he has built several patient and family focused multidisciplinary programs and is actively involved in mentorship programs. He is a reviewer for multiple scientific journals and is an editorial member of 5 journals. He served as president of the American Society of Pediatric Neuroradiology (2014/15) and the Eastern Neuroradiological Society (ENRS) (2020/2021), is a fellow of the International Cancer Imaging Society, the Global Newborn Society, the American College of Radiology, and the American Society Pediatric Neuroradiology. He is the elected President of the International Cancer Imaging Society, 2024-2025. Finally, he served as senior editor of the American Journal of Neuroradiology 2015-2023.
Dr Wan Hang Keith Chiu
Prof Fred Prior
Dr Rosemarie Forstner
Dr Nikolaos Papanikolaou
Nickolas Papanikolaou, PhD (Male), is a Principal Investigator in Oncologic Imaging at CHAMPALIMAUD FOUNDATION and research group leader of the Computational Clinical Imaging Group. He is an Affiliated Researcher at Karolinska Institute and a Senior Affiliated Researcher at the Institute of Computer Science – FORTH. Dr. Nikolaos Papanikolaou studied biomedical engineering while he obtained his Ph.D. from the Medical School of the University of Crete. He has been a research associate of the Department of Radiology, University Hospital of Heraklion, from 1999 to 2009. He has published 85 scientific papers in peer-reviewed international journals, 17 chapters in international books. At the same time, he edited a series of 3 books on Diffusion-Weighted Imaging Applications in GI, GU, and Hepatobiliary systems. He has delivered more than 100 invited lectures in international congresses and educational courses. He served as a member of the editorial board of European Radiology in the section of experimental radiology while he was a member of the abdominal subcommittee of ECR. He has been awarded two research scholarships from ECR. Finally, he is an honorary member of the Spanish Society of Gastrointestinal Radiology (SEDIA). The main focus of his research is the development and validation of imaging biomarkers on cancer applications. He recently initiated the development of a Radiomics Network comprising luminary clinical sites in the US and Europe to advance research in that area of Radiomics. He is the section editor on AI, Radiomics, and Machine Learning in Cancer Imaging, and he is chairing the e-learning subcommittee of ICIS.
Prof Patrick Asbach
Dr. Patrick Asbach is a body imaging radiologist at the Charité in Berlin, Germany. He holds a professorship in diagnostic radiology at the Freie Universität Berlin and the Humboldt Universität zu Berlin. As a committed educator, Dr. Asbach has delivered over 100 lectures at conferences worldwide, and he was scientific organizer of several workshops on urogenital imaging. He has contributed to the literature through book chapters, commentaries, editorials, and over 100 scientific papers in PubMed citable journals.
Dr Jay Heiken
Dr Atul Shinagare
Prof Bachir Taouli
Honorary Secretary
John Carino
Prof Maarten Lequin
Dr Stephan D. Voss
Prof Thorsten Persigehl
Deputy Editor
Prof. Dr. Thorsten Persigehl will support the Journal Cancer Imaging as Deputy Editor from April 2024. Prof. Persigehl holds the professorship of Oncological Imaging and he is Vice-chair at the Department of Diagnostic and Interventional Radiology at the University Hospital of Cologne. The University Hospital of Cologne with his center of integrated oncology (CIO) is one of the largest comprehensive cancer centers in Germany. As part of his clinical work, he is responsible for oncological imaging in general radiology with special expertise in abdominal imaging. Recently he founded the radiological CIO (radCIO) to reflect the increasing specialization and digitalization in radiology, supported by the EU program EFRE. As part of his scientific focus, Prof. Persigehl is investigating, with funding from German Cancer Aid (DKH), how standardized reports can be created in radiology so that this data is available digitally for clinical patient care and oncological research. On the other hand, he is developing algorithms for artificial intelligence (AI) to automatically detect and segment lymph nodes in CT images, determine their anatomic localization as part of the German Research Foundation (DFG) Priority Program 2177. Another focus is on developing and testing AI algorithms that automatically search CT images for signs of an infection that could be linked to COVID-19. In the years 2010 and 2011, he stayed as postdoctoral researcher in the oncological research group of Prof. Lawrence Schwartz at Columbia University Medical Center (CUMC) in New York. Since 2017 he is elected fellow der International Cancer Imaging Society (ICIS) and since 2022 master of oncological imaging (ESOI). Prof. Persigehl is former chairman of the Oncological Working Group of the German Society of Radiology (DRG) and speaker of the Oncological Working Group (ABO) of the German Cancer Foundation (DKG). He is currently involved as author and co-author in over 180 research papers, reviews and book chapters.
Prof Annick Van den Abbeele
Professor Van den Abbeele is Professor of Radiology at Harvard Medical School; Chair Emeritus, Department of Imaging, Founder and Director of the Center for Biomedical Imaging in Oncology, Dana- Farber Cancer Institute; Co-Director of the Tumor Imaging Metrics Core, Dana-Farber/Harvard Cancer Center; Chief Emeritus, Division of Cancer Imaging, Department of Radiology, Mass General Brigham; and Senior Faculty Scholar, Dana-Farber Cancer Institute and Mass General Brigham. Professor Van den Abbeele was recently elected the 2021-2022 President of the International Cancer Imaging Society (ICIS) and serves as co-Editor-in-Chief of the ICIS journal, Cancer Imaging. She is nationally and internationally known for her translational research in molecular imaging, building upon her pioneering work in using imaging to monitor target hit and response to molecularly-targeted therapy and immunotherapy in several cancers. Professor Van den Abbeele is the founder and director of the Center for Biomedical Imaging in Oncology, an integrated clinical and preclinical cancer imaging center co-located with a research-dedicated state-of-the-art cyclotron. She also co-founded and co- directs the Tumor Imaging Metrics Core now established at eight national comprehensive cancer centers. Professor Van den Abbeele has participated in multiple trials testing novel diagnostic and therapeutic agents and helped implement the field of theranostics in multiple cancers. She launched cancer imaging as a new imaging specialty, and the Cancer Imaging Program Fellowship which has grown from one fellow to nine fellows currently who are themselves creating cancer imaging divisions in their own departments. Her major areas of research include translational cancer research using molecular imaging using multidisciplinary integrated pre-clinical and clinical programs, and quantitative tumor imaging metrics. Professor Van den Abbeele is a Fellow of the American College of Radiology (FACR) and of the International Cancer Imaging Society (FICIS). She has received several awards, serves on various national and international scientific advisory boards and review panels, NCI program progress review groups, and several local, national and international committees. Professor Van den Abbeele has mentored over 200 trainees; serves as a PhD thesis advisor, reviewer and faculty mentor; has authored and co-authored more than 300 scientific articles, abstracts, educational materials, book chapters; co- edited 2 textbooks; and presented numerous lectures and workshops nationally and internationally.
Prof Mirko D'Onofrio
Dr Khaled Elsayes
Editor-in-Chief
Prof Giuseppe Petralia
Prof Rodney Reznek
Professor Reznek graduated with honours from the University of Cape Town in 1972, became a Fellow of the Royal College of Radiologists in 1980 and a Fellow of the Royal College of Physicians in 1990. He is the author or co-author of over 200 publications. He is a past Editor-in-Chief of Clinical Radiology, Section Editor of European Radiology, Editor of Cancer Imaging and on the editorial board of two other journals. He is co-founder and Past President of the International Cancer Imaging Society. He has served on the Education and Faculty Boards of the Royal College of Radiologists and been chairman of the Scientific Programme Committee. He has held Visiting Professorships in several countries and given eponymous lectures in the USA, China, and the UK.
Prof Marius Mayerhoefer
Prof Bernhard Gebauer
Dr Richard Gore
Prof Wim Oyen
Honorary Treasurer
Professor Oyen’s main research interests are molecular imaging and radionuclide therapy of cancer. He is the (co-)author of more than 700 original science and review articles in international peer-reviewed journals. He is currently actively involved in the European Association of Nuclear Medicine, the European Cancer Organisation, the Biomedical Alliance, and the Dutch Society of Nuclear Medicine. Professor Oyen also serves as Editorial Board member of various professional journal, including The Journal of Nuclear Medicine and The European Journal of Nuclear Medicine and Molecular Imaging.
Prof Michael Hofman
Dr Subba Digumarthy
Dr Fiona Fennessy
Prof Wolfgang Schima
Maria Antonietta Bali
Rebecca Wiles
Dr Stefan Diederich
Prof Giovanni Morana
Important Details
Abstracts that do not adhere to the following important points will be rejected:
- The title should not exceed 15 words. The title should be in bold, sentence case with no full stop at the end and no underlining.
- The abstract should not exceed 250 words.
- Please use authors’ initials and surnames only. No full stop at the end. Underline the name of the corresponding author. A comma should separate author names. Where authors are from a number of different institutions, the appropriate institution number from the affiliation list should be given as a superscript number immediately after each author’s name, e.g.: John Smith1, Susan Jones1, Bill Fisher2. An asterisk * should be used to link the corresponding author with their email address
- Affiliations should include institute, town and country. Where there are multiple affiliations, each should be listed as a separate paragraph. Each institute should appear in the order used against the author names (see above paragraph) and show the appropriate superscript number, e.g.:
1 University, Town, State, USA
2 University, Town, UK
2 Company, Town, Country
- Qualifications should be omitted.
- Do not include references, tables or figures.
- Please do not use block capitals.
Main text
- In structured abstracts, paragraph headings should be typed in bold with no colon at the end. Do not use the heading ‘Abstract’. Each heading should be in a separate paragraph.
Aim
Followed by regular text, on a new line and in the same format as shown above for main text.
Materials & Methods
Results
Conclusions
Consent to publish
If the abstract contains details relating to individual participants (for example a case report), written informed consent for the publication of these details must be obtained from the participants and a statement to this effect should appear at the end of the abstract. Our guidelines for consent statements can be found here: http://www.biomedcentral.com/about/editorialpolicies#Ethics. If the patient is deceased consent for publication should be obtained from the next of kin and if the patient is under 16 consent should be obtained from the parent or guardian.
You may choose among four different abstract types:
> Oral Scientific Presentation
> Oral Case Based Presentation
> Poster Scientific Presentation
> Poster Educational Presentation
Oral Scientific Presentation
The abstract should be separated into “Aim”, “Methods”, “Results” and “Conclusion”. The abstract limit is 250 words. Abstracts should not include promissory notes such as “We will provide additional data during our presentation.” Authors of accepted oral presentations will be invited for a presentation within the Scientific Paper Sessions. Presentation time will be 8 minutes with 2 minutes for Q&A (depending on the final program).
Oral Case Based Presentation
The abstract should have an image and three teaching points. The abstract limit is 250 words. Abstracts should not include promissory notes such as “We will provide additional data during our presentation.” Authors of accepted oral case based presentations will be invited for a presentation within the Scientific Paper Sessions. Presentation time will be 8 minutes with 2 minutes for Q&A (depending on the final program).
Poster Scientific Presentation
The abstract should be separated into “Aim”, “Methods”, “Results” and “Conclusion”. The abstract limit is 250 words.
Poster Educational Presentation
The abstract should be separated into “Learning Objectives”, “Content Organisation” and “Conclusion”. The abstract limit is 250 words.
Proceedings of the 24th International Cancer Imaging
Abstracts selected for presentation will be published in the Proceedings of the 24th International Cancer Imaging, given to all delegates and faculty. A downloadable version of your submission will be made available to our membership on the members only area of our website, and be available on the Cancer Imaging open access website. Authors of selected abstracts will be notified after 30 June 2025.
How to submit
It will be obligatory for all scientific presenters to be members of ICIS at the time of presentation in The Hague. The annual membership fee of €90 will be added to the scientific presenters’ fee at registration if current membership is not in place. Please note that we have a discounted trainee membership at €45 and a much reduced trainee registration fee for the course. Membership will run for one year from date of registration; all standard member benefits will apply.
To submit your abstract, please click the link below. You’ll be redirected to Oxford Abstracts, a separate platform that we use for handling submissions. Please follow the instructions on their site to complete your submission.
Queries may be addressed to the ICIS Secretariat
Email: [email protected]
Terms and conditions of website use
This page (together with the documents referred to on it) tells you the terms of use on which you may make use of our website www.cancerimagingsociety.org.uk (“our site”), whether as a guest or a registered user. Please read these terms of use carefully before you start to use the site. By using our site, you indicate that you accept these terms of use and that you agree to abide by them. If you do not agree to these terms of use, please refrain from using our site.
Various elements of our site are subject to additional terms and conditions, which supplement these terms. The additional terms and conditions are brought to your intention where appropriate.
Click here for additional information.
